Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)

被引:29
作者
Zheng, Zhaohua [1 ,2 ]
Pinson, Jo-Anne [1 ]
Mountford, Simon J. [1 ]
Orive, Stephanie [2 ]
Schoenwaelder, Simone M. [2 ,4 ,5 ]
Shackleford, David [3 ]
Powell, Andrew [3 ]
Nelson, Erin M. [2 ]
Hamilton, Justin R. [2 ]
Jackson, Shaun P. [2 ,4 ,5 ]
Jennings, Ian G. [1 ]
Thompson, Philip E. [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia
[2] Monash Univ, AMREP, Australian Ctr Blood Dis, 89 Commercial Rd, Prahran, Vic 3004, Australia
[3] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia
[4] Univ Sydney, Heart Res Inst, Sydney, NSW 2006, Australia
[5] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia
基金
英国医学研究理事会;
关键词
PI3; kinase; Kinase selectivity; Platelet aggregation inhibitors; Thrombosis; NONCONSERVED AMINO-ACIDS; PHOSPHOINOSITIDE; 3-KINASE; INTEGRIN ALPHA(IIB)BETA(3); ANTITHROMBOTIC AGENT; P110-BETA ISOFORM; IN-VITRO; PLATELETS; TARGET; IDENTIFICATION; DERIVATIVES;
D O I
10.1016/j.ejmech.2016.06.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of amino-substituted triazines were developed and examined for PI3K13 inhibition and anti platelet function. Structural adaptations of a morpholine ring of the prototype pan-PI3K inhibitor ZSTK474 yielded PI3K beta selective compounds, where the selectivity largely derives from an interaction with the non-conserved Asp862 residue, as shown by site directed mutagenesis. The most PI3K beta selective inhibitor from the series was studied in detail through a series of in vitro and in vivo functional studies. MIPS-9922, 10 potently inhibited ADP-induced washed platelet aggregation. It also inhibited integrin alpha(IIb)beta(3) activation and alpha(IIb)beta(3) dependent platelet adhesion to immobilized vWF under high shear. It prevented arterial thrombus formation in the in vivo electrolytic mouse model of thrombosis without inducing prolonged bleeding or excess blood loss. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:339 / 351
页数:13
相关论文
共 29 条
  • [1] Discovery of (R)-8-(1-(3,5-Difluorophenylamino)ethyl)-N,N-dimethy12-morpholino-4-oxo-4H-chromene-6-carboxamide (AZD8186): A Potent and Selective Inhibitor of PI3Kβ and P13Kδ for the Treatment of PTEN-Deficient Cancers
    Barlaam, Bernard
    Cosulich, Sabina
    Degorce, Sebastien
    Fitzek, Martina
    Green, Stephen
    Hancox, Urs
    Lambert-van der Brempt, Christine
    Lohmann, Jean-Jacques
    Maudet, Mickael
    Morgentin, Remy
    Pasquet, Marie-Jeanne
    Peru, Aurelien
    Ple, Patrick
    Saleh, Twana
    Vautier, Michel
    Walker, Mike
    Ward, Lara
    Warin, Nicolas
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (02) : 943 - 962
  • [2] Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours
    Barlaam, Bernard
    Cosulich, Sabina
    Degorce, Sebastien
    Fitzek, Martina
    Giordanetto, Fabrizio
    Green, Stephen
    Inghardt, Tord
    Hennequin, Laurent
    Hancox, Urs
    Lambert-van der Brempt, Christine
    Morgentin, Remy
    Pass, Sarah
    Ple, Patrick
    Saleh, Twana
    Ward, Lara
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3928 - 3935
  • [3] PLATELET-AGGREGATION MONITORED IN A 96-WELL MICROPLATE READER IS USEFUL FOR EVALUATION OF PLATELET AGONISTS AND ANTAGONISTS
    BEDNAR, B
    CONDRA, C
    GOULD, RJ
    CONNOLLY, TM
    [J]. THROMBOSIS RESEARCH, 1995, 77 (05) : 453 - 463
  • [4] Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-β inhibitor in mice
    Bird, J. Eileen
    Smith, Patricia L.
    Bostwick, Jeffrey S.
    Shipkova, Petia
    Schumacher, William A.
    [J]. THROMBOSIS RESEARCH, 2011, 127 (06) : 560 - 564
  • [5] Genetic evidence for a predominant role of PI3Kβ catalytic activity in ITAM- and integrin-mediated signaling in platelets
    Canobbio, Ilaria
    Stefanini, Lucia
    Cipolla, Lina
    Ciraolo, Elisa
    Gruppi, Cristian
    Balduini, Cesare
    Hirsch, Emilio
    Torti, Mauro
    [J]. BLOOD, 2009, 114 (10) : 2193 - 2196
  • [6] Discovery and Optimization of Pyrimidone Indoline Amide P13Kβ Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers
    Certal, Victor
    Carry, Jean-Christophe
    Halley, Frank
    Virone-Oddos, Angela
    Thompson, Fabienne
    Filoche-Romme, Bruno
    El-Ahmad, Youssef
    Karlsson, Andreas
    Charrier, Veronique
    Delorme, Cecile
    Rak, Alexey
    Abecassis, Pierre-Yves
    Amara, Celine
    Vincent, Loic
    Bonnevaux, Helene
    Nicolas, Jean-Paul
    Mathieu, Magali
    Bertrand, Thomas
    Marquette, Jean-Pierre
    Michot, Nadine
    Benard, Tsiala
    Perrin, Marc-Antoine
    Lemaitre, Olivier
    Guerif, Stephane
    Perron, Sebastien
    Monget, Sylvie
    Gruss-Leleu, Florence
    Doerflinger, Gilles
    Guizani, Houlfa
    Brollo, Maurice
    Delbarre, Laurence
    Benin, Luc
    Richepin, Patrick
    Loyau, Veronique
    Garcia-Echeverria, Carlos
    Lengauer, Christoph
    Schio, Laurent
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) : 903 - 920
  • [7] Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl) amide derivatives as PI3Kβ inhibitors
    Certal, Victor
    Halley, Frank
    Virone-Oddos, Angela
    Thompson, Fabienne
    Filoche-Romme, Bruno
    El-Ahmad, Youssef
    Carry, Jean-Christophe
    Delorme, Cecile
    Karlsson, Andreas
    Abecassis, Pierre-Yves
    Vincent, Loic
    Bonnevaux, Helene
    Nicolas, Jean-Paul
    Morales, Renaud
    Michot, Nadine
    Vade, Isabelle
    Louboutin, Audrey
    Perron, Sebastien
    Doerflinger, Gilles
    Tric, Bernadette
    Monget, Sylvie
    Lengauer, Christoph
    Schio, Laurent
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6381 - 6384
  • [8] Protein kinases - the major drug targets of the twenty-first century?
    Cohen, P
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
  • [9] P2Y12 platelet inhibition in clinical practice
    Damman, Peter
    Woudstra, Pier
    Kuijt, Wichert J.
    de Winter, Robbert J.
    James, Stefan K.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (02) : 143 - 153
  • [10] Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket
    Frazzetto, Mark
    Suphioglu, Cenk
    Zhu, Jiuxiang
    Schmidt-Kittler, Oleg
    Jennings, Ian G.
    Cranmer, Susan L.
    Jackson, Shaun P.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Thompson, Philip E.
    [J]. BIOCHEMICAL JOURNAL, 2008, 414 (03) : 383 - 390